Last checked at 1 Nov 2018 15:53
1 November 2018
Kainos Group plc
("Kainos" or the "Company")
Block Admission
Kainos announces that an application has been made to the Financial Conduct Authority and the London Stock Exchange for a total of 1,000,000 ordinary shares of 0.5 pence each (the "Shares") to be admitted to the Official List.
The Shares are expected to be admitted to the Official List and to trading on the London Stock Exchange on 6 November 2018.
These Shares are being reserved under a block listing and will be issued as a result of the award of shares pursuant to the Company's long term incentive plans, and SAYE plans, as follows:
2015 SAYE | 250,000 |
2015 PSP | 220,000 |
2015 CSOP | 430,000 |
POLAND 2015 | 60,000 |
2015 RSS (ROI) | 40,000 |
TOTAL | 1,000,000 |
When issued, these Shares will rank pari passu with the existing ordinary shares.
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47
Ends
For further information, please contact:
Kainos via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
Investec Bank plc +44 20 7597 5970
Patrick Robb / Sebastian Lawrence
Canaccord Genuity +44 20 7523 4606
Simon Bridges / Emma Gabriel
FTI Consulting LLP +44 20 3727 1000
Matt Dixon / Harry Staight
About Kainos
Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.
The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.
Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com